This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Switching Antipsychotic Medications

Peter J. Weiden, M.D., Ralph Aquila, M.D., Laura Dalheim, M.D., and Janet M. Standard, R.N.

Published: November 1, 1997

Article Abstract

Compared with conventional antipsychotics, the so-called "atypical" antipsychotics promise improvedside effect profiles and better control of the symptoms of schizophrenia. Therefore, most patientscurrently taking conventional antipsychotics could potentially benefit from a switch to an atypicalantipsychotic. Often, the key issue in deciding whether to switch is the presence of countervailingfactors that mitigate against the change. This paper discusses the indications and contraindications forswitching antipsychotics, plus issues that require consideration before a switch is made. Also, the advantagesand disadvantages of various switching techniques are discussed, with a particular focus onthe newer antipsychotic olanzapine.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 58

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...